Metformin ER (extended-release) costs significantly more than its immediate-release counterpart, and the reasons come down to formulation complexity, market disruptions from contamination recalls, and massive price gaps between brand-name and generic versions. The brand-name version (Fortamet) has an average retail price around $1,064 for a typical monthly supply, though generic versions and discount coupons can bring that down to roughly $25 to $50.
Extended-Release Formulation Costs More to Make
Standard metformin (immediate-release) is one of the cheapest drugs on the market. It’s a simple tablet that dissolves quickly in your stomach, and it’s been produced by dozens of manufacturers for decades. Extended-release metformin uses more sophisticated delivery technology. The tablets are engineered to dissolve slowly over many hours, which requires specialized manufacturing processes like gel matrices or controlled-release polymer systems. These added steps raise production costs compared to a basic pressed tablet.
That said, the manufacturing cost difference alone doesn’t explain the prices patients see at the pharmacy counter. The bigger factors are market dynamics and how brand-name pricing works in the U.S. pharmaceutical system.
NDMA Recalls Disrupted the Supply Chain
Starting in 2020, the FDA recommended that five manufacturers of metformin ER recall specific lots of their tablets after testing found NDMA, a probable carcinogen, at levels above acceptable limits. This was a significant hit to the supply chain. While the FDA noted that additional manufacturers supplying “the bulk of the US market” were not affected, the recalls still reduced the number of active suppliers and created uncertainty.
When manufacturers exit a market, even temporarily, competition drops and prices tend to rise. The remaining producers face less pressure to undercut each other, and pharmacy buyers have fewer options to shop around. The NDMA issue also forced manufacturers to invest in additional testing and quality controls, costs that get passed along to consumers.
Fewer Competitors Than You’d Expect
Despite metformin being one of the most widely prescribed drugs in the world, the number of companies actually producing metformin ER is more limited than you might think. Medicaid data from 2021 showed 21 labelers in the database for metformin ER products, but just 9 of them accounted for 98.2% of all claims filled. That level of market concentration means a handful of companies control nearly all the supply, which limits the price competition that normally drives generic drug costs down over time.
The immediate-release market showed similar concentration numbers (9 of 21 labelers covering about 64% of claims), but immediate-release metformin has been generic far longer and benefits from a much larger total production volume. More competition over a longer period has pushed IR prices to rock-bottom levels, sometimes just a few dollars per month. The ER market hasn’t reached that same level of price erosion.
Brand-Name Versions Drive Sticker Shock
If you’ve been quoted a price of several hundred dollars or more, there’s a good chance you were looking at a brand-name version. Fortamet and Glumetza are the two main brand-name metformin ER products, and their pricing reflects the premium that brand-name drugs carry in the U.S. market. Fortamet’s average retail price sits around $1,064 for a common monthly prescription. That price has little to do with the cost of the drug itself and much more to do with pharmaceutical pricing strategies, patent protections on specific formulations, and the lack of price regulation in the American system.
The gap between brand and generic is enormous. At Walgreens, Fortamet lists around $424, while at CVS with a discount coupon, the same drug drops to about $30. Walmart and Costco fall somewhere in between at $51 and $168 respectively. These wild swings in price for the same medication at different pharmacies highlight how much of the cost comes from pharmacy markup and negotiation rather than the drug’s actual value.
How to Pay Less for Metformin ER
The most important step is making sure your pharmacy is dispensing a generic version, not Fortamet or Glumetza. If your prescription is written for a brand name, ask your doctor to switch it to generic metformin ER. Most insurance plans cover generic metformin ER as a preferred formulary item. The VA system, for example, lists it as a Tier 2 formulary drug with a standard copay.
If you’re uninsured or your insurance doesn’t cover it well, pharmacy discount tools like GoodRx can cut the price dramatically. The difference between walking into a pharmacy without a coupon and using one can be the difference between paying over $400 and paying under $30 for the exact same medication. Prices also vary significantly between pharmacies, so it’s worth comparing. Grocery store pharmacies and big-box retailers like Walmart and Costco tend to offer lower prices than chain drugstores.
If your doctor is open to it, switching from metformin ER to immediate-release metformin is another option. The IR version is often available for under $10 per month and sometimes free through pharmacy discount programs. The tradeoff is taking the medication two or three times daily instead of once, and some people experience more stomach-related side effects with the IR version. For many patients, the ER formulation exists specifically because it’s easier on the digestive system, so this switch isn’t right for everyone.